COVID-19 期间移植受者长期治疗抵抗性疣的清除。
Clearance of longstanding treatment-resistant warts during COVID-19 in a transplant recipient.
机构信息
Department of Dermatology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
出版信息
Transpl Infect Dis. 2021 Aug;23(4):e13572. doi: 10.1111/tid.13572. Epub 2021 Feb 16.
Abstract
Human papillomavirus (HPV), a DNA virus, infects basal keratinocytes and causes common warts and as well as malignancies of skin and mucous membranes. Although many treatment options are available, persistent HPV infections are common among transplant recipients. Herein, we present a patient with a 15-year history of treatment-resistant warts that regressed during COVID-19 (Coronavirus disease 2019) treatment.
摘要
人乳头瘤病毒（HPV）是一种 DNA 病毒，感染基底角质形成细胞，引起常见疣以及皮肤和黏膜的恶性肿瘤。尽管有许多治疗选择，但移植受者中 HPV 感染持续存在很常见。在此，我们介绍了一位患有 15 年难治性疣病史的患者，在 COVID-19（2019 年冠状病毒病）治疗期间，其疣消退。
相似文献
1
Clearance of longstanding treatment-resistant warts during COVID-19 in a transplant recipient.COVID-19 期间移植受者长期治疗抵抗性疣的清除。
Transpl Infect Dis. 2021 Aug;23(4):e13572. doi: 10.1111/tid.13572. Epub 2021 Feb 16.
2
Clearance of recalcitrant warts in a pediatric patient following administration of the nine-valent human papillomavirus vaccine.一名儿科患者在接种九价人乳头瘤病毒疫苗后顽固性疣的清除情况。
Pediatr Dermatol. 2020 Jul;37(4):748-749. doi: 10.1111/pde.14150. Epub 2020 Mar 15.
3
Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds.疣：发病机制、类型、治疗方法和药物化合物。
Int J Pharm Compd. 2023 May-Jun;27(3):182-190.
4
[Human papillomavirus-associated warts in organ transplant recipients. Incidence, risk factors, management].[器官移植受者中与人乳头瘤病毒相关的疣。发病率、危险因素及管理]
Hautarzt. 2010 Mar;61(3):220-9. doi: 10.1007/s00105-009-1860-8.
5
Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.实体器官移植受者人乳头瘤病毒感染：美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13590. doi: 10.1111/ctr.13590. Epub 2019 Jun 20.
6
Plasmacytoid dendritic cell and type I interferons as possible explanation for clearance of longstanding warts during COVID-19 in a transplant patient, reply to Erkayman et al.浆细胞样树突状细胞和I型干扰素：一名移植患者在感染新冠病毒期间长期疣清除的可能解释，对埃尔凯曼等人的回应
Transpl Infect Dis. 2021 Aug;23(4):e13585. doi: 10.1111/tid.13585. Epub 2021 Feb 26.
7
COVID-19 and human papillomavirus: Paradoxical immunity.COVID-19 与人类乳头瘤病毒：矛盾免疫。
J Cosmet Dermatol. 2021 Jul;20(7):2001-2003. doi: 10.1111/jocd.14022. Epub 2021 Mar 9.
8
Viral warts in organ transplant recipients: new aspects in therapy.器官移植受者的病毒疣：治疗新进展
Br J Dermatol. 2003 Nov;149 Suppl 66:20-4. doi: 10.1046/j.0366-077x.2003.05627.x.
9
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients.肾移植受者和非免疫抑制患者非黑素瘤皮肤癌中的人乳头瘤病毒感染
J Natl Cancer Inst. 1996 Jun 19;88(12):802-11. doi: 10.1093/jnci/88.12.802.
10
Human papillomavirus infection and skin cancer risk in organ transplant recipients.器官移植受者中的人乳头瘤病毒感染与皮肤癌风险
J Investig Dermatol Symp Proc. 2001 Dec;6(3):207-11. doi: 10.1046/j.0022-202x.2001.00048.x.
引用本文的文献
1
A case of chronic kidney disease patient with rapid deterioration of renal function, hair loss, and spontaneous resolution of facial warts after COVID-19 infection.一例慢性肾脏病患者在感染新型冠状病毒肺炎后肾功能迅速恶化、脱发且面部疣自发消退。
Aging Med (Milton). 2024 Jan 31;7(1):131-135. doi: 10.1002/agm2.12281. eCollection 2024 Feb.
2
Resolution of recalcitrant verruca following Moderna COVID-19 vaccination in a person with HIV.一名感染HIV的患者在接种Moderna新冠疫苗后顽固性疣消退
JAAD Case Rep. 2023 Jan;31:118-120. doi: 10.1016/j.jdcr.2022.11.007. Epub 2022 Nov 12.
3
Clearance of recalcitrant verruca plana following COVID-19 vaccination.新冠病毒疫苗接种后顽固性扁平疣的清除
JAAD Int. 2022 Sep;8:1-2. doi: 10.1016/j.jdin.2022.02.007. Epub 2022 Mar 16.
4
Regression of common viral warts after ChAdOx1-S COVID-19 vaccine.ChAdOx1-S新冠疫苗接种后寻常疣消退
J Eur Acad Dermatol Venereol. 2022 Mar;36(3):e162-e164. doi: 10.1111/jdv.17771. Epub 2021 Nov 13.
5
Insights into the management of anorectal disease in the coronavirus 2019 disease era.2019年冠状病毒病时代肛管直肠疾病管理的见解
Therap Adv Gastroenterol. 2021 Jul 9;14:17562848211028117. doi: 10.1177/17562848211028117. eCollection 2021.
6
Plasmacytoid dendritic cell and type I interferons as possible explanation for clearance of longstanding warts during COVID-19 in a transplant patient, reply to Erkayman et al.浆细胞样树突状细胞和I型干扰素：一名移植患者在感染新冠病毒期间长期疣清除的可能解释，对埃尔凯曼等人的回应
Transpl Infect Dis. 2021 Aug;23(4):e13585. doi: 10.1111/tid.13585. Epub 2021 Feb 26.
本文引用的文献
1
SARS-CoV-2, COVID-19, skin and immunology - What do we know so far?SARS-CoV-2、COVID-19、皮肤与免疫学：目前我们了解多少？
Allergy. 2021 Mar;76(3):698-713. doi: 10.1111/all.14498. Epub 2020 Aug 12.
2
Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems.揭开新冠病毒细胞因子风暴之谜：从皮肤到器官系统。
Dermatol Ther. 2020 Nov;33(6):e13859. doi: 10.1111/dth.13859. Epub 2020 Jul 7.
3
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.COVID-19 皮肤表现分类：西班牙 375 例快速前瞻性全国共识研究。
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
4
Coronavirus infections and immune responses.冠状病毒感染与免疫应答。
J Med Virol. 2020 Apr;92(4):424-432. doi: 10.1002/jmv.25685. Epub 2020 Feb 7.
5
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.法匹拉韦（T-705），一种病毒RNA聚合酶的广谱抑制剂。
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449-463. doi: 10.2183/pjab.93.027.
6
Natural course of cutaneous warts among primary schoolchildren: a prospective cohort study.小学生皮肤疣的自然病程：一项前瞻性队列研究。
Ann Fam Med. 2013 Sep-Oct;11(5):437-41. doi: 10.1370/afm.1508.
7
Benign human papillomavirus infection in renal transplant recipients.肾移植受者的人乳头瘤病毒良性感染
Int J Dermatol. 1991 Nov;30(11):785-9. doi: 10.1111/j.1365-4362.1991.tb04787.x.
Zotero 插件